SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients.
Published on Jul 1, 2021in American Journal of Transplantation7.338
· DOI :10.1111/AJT.16744
Sherif B. Mossad25
Estimated H-index: 25
On June 8th , Malinis et al, published their preliminary observations of the SARS-CoV-2 vaccine effectiveness in solid organ transplant recipients (SOTR) in the AJT (1). Their timely, real world results based on current practices are reassuring. Several studies have now shown 100% effectiveness of multiple SARS-CoV-2 vaccines in preventing hospitalization and death. As of May 17th , 2021, 860 of 123 million (0.0008%) who were fully vaccinated developed breakthrough infections that required hospitalization or were fatal.